AHCO Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -10.03%, SMA50 -10.96%, SMA200 -4.14%). The stock’s 14-day RSI is 36.77 (weak momentum), while the ATR of 0.5 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.93% below its high and over 27.8% above its low. Average 10-day trading volume of 883.24 thousand shares is below the 3-month average of 1.37 million, indicating normal recent market interest.

AdaptHealth Corp. has 136.05 million shares outstanding. The public float is 85.69 million shares, elevated short interest at 7.32% of float. This equals 7.54 million shares. The short ratio is 5.03 days. Institutional investors hold 113.32% of the float. Insiders own 8.12%. OEP VII GP, L.L.C. holds 16.31 million shares, CASHIN RICHARD M JR has 16.31 million shares and Everest Hill Group Inc. has 12.81 million shares. Over the past six months, insider transactions show net buying. They sold 11.28 thousand shares across 1 transactions.

AdaptHealth Corp. generated EPS of -$0.53 over the past year. Five-year average earnings growth is 29.83%. Wall Street analysts project EPS growth of 29.34% annually over the next five years. The latest quarter delivered EPS of -$0.06. The next quarter is forecast at $0.01. Next year's EPS is expected at -$3.59. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $16.00 to $13.00. The high target offers 57.48% upside. The low target suggests 27.95% downside. The mean target is $14.50. This offers 42.72% upside. AdaptHealth Corp. earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by -580.0%. The prior quarter beat by -20.59%. Over the last six quarters, Apple has recorded several small beats. These include 56.0% in February 25, 2025.

AdaptHealth Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $23.01. This means the shares are trading below this model’s fair value.

AdaptHealth Corp. (NASDAQ:AHCO) shares are flat 4.42% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows AdaptHealth Corp. trading at a premium to the broader market with a P/E of -17.32. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $19.15, suggesting 88.48% upside. Our AI forecast model points to short-term weakness (-9.06% over two weeks), a medium-term rise (212.89% over three months), and a longer-term gain (171.06% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that AdaptHealth Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.06%, with price expected at $9.24 by June 26, 2026, within a range of $8.69 to $9.74 3-Month Outlook: Projected rise of 212.89%, reaching $31.79 by September 10, 2026, with a range of $31.58 to $32.43. 1-Year Outlook: Projected gain of 171.06%, with price at $27.54 by June 11, 2027, within a range of $26.69 to $33.31.

AdaptHealth Corp. (NASDAQ:AHCO) closed at $9.98 USD, losing -$0.18 (-1.72%) from the previous close of $10.16. The stock is currently mid-range between its 52-week high and low $8.06 and $13.43. With a market capitalization of about $1.36 billion, AdaptHealth Corp. is classified as a small-cap and shows higher-than-market volatility (beta ~1.46). Key stats such as the average daily volume over the past year has been around 1.38 million shares, volume is running light vs its 52-week average. Headquartered in Plymouth Meeting, PA, AdaptHealth Corp. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Suzanne Foster, the company employs approximately 10,500 people and listed since May 31, 2018. AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States.

AdaptHealth Corp. trades at a P/E ratio of -17.32, slightly below the S&P 500 average, with a price-to-sales ratio of 0.48 and a price-to-book ratio of 0.92 suggesting the stock is closer to book value. The P/FCF stands at 7.2, also above market averages.